Ad is loading...
ATEC
Price
$10.21
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
102 days until earnings call
EKSO
Price
$0.72
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
97 days until earnings call
Ad is loading...

ATEC vs EKSO

Header iconATEC vs EKSO Comparison
Open Charts ATEC vs EKSOBanner chart's image
Alphatec Holdings
Price$10.21
Change-$0.00 (-0.00%)
Volume$1.64M
CapitalizationN/A
Ekso Bionics Holdings
Price$0.72
Change-$0.00 (-0.00%)
Volume$75.86K
CapitalizationN/A
ATEC vs EKSO Comparison Chart
Loading...
ATEC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
EKSO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ATEC vs. EKSO commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATEC is a StrongBuy and EKSO is a Hold.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (ATEC: $10.21 vs. EKSO: $0.72)
Brand notoriety: ATEC and EKSO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ATEC: 71% vs. EKSO: 99%
Market capitalization -- ATEC: $1.9B vs. EKSO: $24.35M
ATEC [@Medical Specialties] is valued at $1.9B. EKSO’s [@Medical Specialties] market capitalization is $24.35M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATEC’s FA Score shows that 0 FA rating(s) are green whileEKSO’s FA Score has 1 green FA rating(s).

  • ATEC’s FA Score: 0 green, 5 red.
  • EKSO’s FA Score: 1 green, 4 red.
According to our system of comparison, both ATEC and EKSO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATEC’s TA Score shows that 5 TA indicator(s) are bullish while EKSO’s TA Score has 4 bullish TA indicator(s).

  • ATEC’s TA Score: 5 bullish, 4 bearish.
  • EKSO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ATEC is a better buy in the short-term than EKSO.

Price Growth

ATEC (@Medical Specialties) experienced а +16.95% price change this week, while EKSO (@Medical Specialties) price change was -5.14% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.14%. For the same industry, the average monthly price growth was +0.91%, and the average quarterly price growth was -2.33%.

Reported Earning Dates

ATEC is expected to report earnings on Mar 04, 2025.

EKSO is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Medical Specialties (+3.14% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATEC($1.9B) has a higher market cap than EKSO($24.3M). ATEC YTD gains are higher at: -32.429 vs. EKSO (-71.200). EKSO has higher annual earnings (EBITDA): -13.2M vs. ATEC (-110.59M). ATEC has more cash in the bank: 221M vs. EKSO (8.64M). EKSO has less debt than ATEC: EKSO (7.17M) vs ATEC (542M). ATEC has higher revenues than EKSO: ATEC (482M) vs EKSO (18.3M).
ATECEKSOATEC / EKSO
Capitalization1.9B24.3M7,831%
EBITDA-110.59M-13.2M838%
Gain YTD-32.429-71.20046%
P/E RatioN/AN/A-
Revenue482M18.3M2,634%
Total Cash221M8.64M2,558%
Total Debt542M7.17M7,561%
FUNDAMENTALS RATINGS
ATEC vs EKSO: Fundamental Ratings
ATEC
EKSO
OUTLOOK RATING
1..100
2555
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
31
Undervalued
PROFIT vs RISK RATING
1..100
70100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3691
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EKSO's Valuation (31) in the Medical Specialties industry is significantly better than the same rating for ATEC (98). This means that EKSO’s stock grew significantly faster than ATEC’s over the last 12 months.

ATEC's Profit vs Risk Rating (70) in the Medical Specialties industry is in the same range as EKSO (100). This means that ATEC’s stock grew similarly to EKSO’s over the last 12 months.

EKSO's SMR Rating (98) in the Medical Specialties industry is in the same range as ATEC (100). This means that EKSO’s stock grew similarly to ATEC’s over the last 12 months.

ATEC's Price Growth Rating (36) in the Medical Specialties industry is somewhat better than the same rating for EKSO (91). This means that ATEC’s stock grew somewhat faster than EKSO’s over the last 12 months.

ATEC's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as EKSO (100). This means that ATEC’s stock grew similarly to EKSO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATECEKSO
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
80%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ATEC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
EKSO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMSGX21.650.34
+1.60%
VALIC Company I Mid Cap Strategic Gr
VMGIX104.301.33
+1.29%
Vanguard Mid-Cap Growth Index Investor
FTAEX11.710.01
+0.09%
Fidelity Advisor Total Intl Equity A
MMZMX23.45N/A
N/A
MassMutual Blue Chip Growth Y
GARSX9.92N/A
N/A
Goldman Sachs Global Rl Estt Secs Instl

ATEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATEC has been loosely correlated with LAB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ATEC jumps, then LAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATEC
1D Price
Change %
ATEC100%
+2.82%
LAB - ATEC
50%
Loosely correlated
+0.62%
GMED - ATEC
45%
Loosely correlated
+1.58%
TMCI - ATEC
41%
Loosely correlated
-0.50%
TFX - ATEC
36%
Loosely correlated
+1.71%
BIO - ATEC
34%
Loosely correlated
+0.58%
More

EKSO and

Correlation & Price change

A.I.dvisor tells us that EKSO and ATEC have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EKSO and ATEC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EKSO
1D Price
Change %
EKSO100%
+0.14%
ATEC - EKSO
25%
Poorly correlated
+2.82%
GENE - EKSO
25%
Poorly correlated
N/A
ICLR - EKSO
24%
Poorly correlated
+4.46%
MASS - EKSO
24%
Poorly correlated
+7.03%
CDNA - EKSO
23%
Poorly correlated
+0.94%
More